{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "60001033",
    "licUnit": "1",
    "validDate": "2026-12-02 00:00:00.000",
    "issueDate": "2016-12-02 00:00:00.000",
    "oriIssueDate": "2016-12-02",
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA06000103302",
    "prodNameC": "瑞百安注射液",
    "prodNameE": "Repatha Solution for Injection",
    "indicationsName": [
        "1.對於已確診心血管疾病的成年病人，可降低心肌梗塞、中風及冠狀動脈血管重建術的風險。\r\n2.可單獨使用或併用其他降低密度脂蛋白膽固醇 (LDL-C)藥物，作為飲食外的輔助治療以降低原發性高脂血症(包含異合子家族性高膽固醇血症[HeFH])成人病人之 LDL-C。\r\n3.作為飲食及併用其他降低密度脂蛋白膽固醇(LDL-C)藥物的輔助治療，以降低10 歲以上異合子家族性高膽固醇血症(HeFH)兒童及青少年病人之LDL-C。"
    ],
    "does": "2279",
    "packageUnit": [
        {
            "packageSpec": "1mL",
            "packageUnit": "3Y"
        },
        {
            "packageSpec": "1mL",
            "packageUnit": "7M"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "72FD5069-F4DB-4525-A7A0-C4BCA6E95508",
    "subCategory": [],
    "ingredientsDesc": [
        "Evolocumab"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "07 新藥監視",
        "5F 免除銜接性試驗"
    ],
    "applicantName": "台灣安進藥品有限公司 ",
    "applicantAddr": "臺北市信義區松仁路100號13樓之1、之2",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2021-12-02",
    "licidNew": null,
    "licidOld": null,
    "manuImportDesc": "廠商未登錄資料",
    "licManuImport": "2",
    "factoryDtoList": [
        {
            "id": "58EAEA1A-B857-42DE-B5C6-171699BF9052",
            "factoryCode": "1",
            "factoryName": "AMGEN MANUFACTURING LIMITED LLC",
            "factoryAddr": "STATE ROAD 31, KM 24.6 JUNCOS, PUERTO RICO 00777-4060",
            "factoryCompanyAddr": "",
            "countryCode": "PR",
            "processCode": [
                {
                    "value": "2I",
                    "name": "原料藥及成品製造廠"
                }
            ],
            "processCodeStr": "2I;原料藥及成品製造廠",
            "factoryKind": "M",
            "factoryNo": "FPR0062100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "A5A76241-EDCA-4826-BF64-C1C4803BB4C0",
            "factoryCode": "2",
            "factoryName": "IMMUNEX RHODE ISLAND CORPORATION",
            "factoryAddr": "40 TECHNOLOGY WAY, WEST GREENWICH RHODE ISLAND 02817, USA",
            "factoryCompanyAddr": "",
            "countryCode": "US",
            "processCode": [
                {
                    "value": "1K",
                    "name": "原料藥製造廠"
                }
            ],
            "processCodeStr": "1K;原料藥製造廠",
            "factoryKind": "M",
            "factoryNo": "FUS0866000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "2406004500",
            "ingredientsName": "Evolocumab",
            "ingredientsDesc": "Evolocumab",
            "concentDesc": "",
            "concent": "140.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "C10AX13"
        }
    ],
    "licBaseId": "21C7404F-1E09-4525-9295-B2161404EC68"
}